In 2021 it was estimated that 75% of worldwide dementia cases are undiagnosed.¹ Dementia, especially in its early stages, remains underdetected, underdiagnosed, underdisclosed, and undermanaged.¹ #AlzheimersAwareness

Unfortunately, today there is still a stigma around #AlzheimersDisease (AD) sometimes preventing patients and care partners to seek advice from HCPs when early symptoms arise.¹ This can ultimately lead to a diagnosis at a later stage of AD. #AlzheimersAwareness

Patients may hide symptoms or avoid making an appointment with their doctor until symptoms significantly affect their life.² We asked Prof. Dr. Laura Bonanni if knowledge and understanding could reduce the fear of stigma associated with #AlzheimersDisease. Watch her response.

PET biomarker imaging in #AlzheimersDisease can add precision to diagnosis and enhance physicians’ diagnostic confidence enabling access to the proper treatment and improving patient management.¹⁻⁵ #AlzheimersAwareness

The analysis of cerebrospinal fluid (CSF) can help in the diagnosis, monitoring, and management of #AlzheimersDisease. To reduce the risk of complications after a lumbar puncture there are several recommendations.¹⁻⁴ #AlzheimersAwareness

The early and accurate detection of #AlzheimersDisease enables patients and their care partners to plan for the future and make appropriate lifestyle changes that could help maintain their quality of life for longer.³ Watch Dr. Massa’s opinion on this topic here:

Practice recommendations - patient-centered #AlzheimersDisease care¹,²: 1 know the individual​ 2 recognize & accept the individual’s reality​ 3 create opportunities for meaningful engagement​ 4 caring relationships​ 5 compassionate community​ 6 evaluate care practices regularly

How do you keep yourself up-to-date about novel findings in #AlzheimersDisease?

Only ten more days until the start of #AAIC24 in Philadelphia! We hope you are as excited as we are to meet clinicians and researchers from across the globe and learn about the latest scientific developments in #AlzheimersDisease.

Today we want to raise awareness for #BrainHealthandPrevention. Addressing the rapidly increasing global burden of neurological disorders requires a strong commitment to action at individual, organizational, and various societal levels.¹ Join the conversation! #WorldBrainDay!

Attending a conference is always a great possibility to learn about the latest research highlights. At the #ADPD2024 in Lisbon a few months ago, one intriguing topic was the brain-gut interaction. Watch Prof. Ono’s insights on this topic here: #AlzheimersDisease

We are ready to meet you at the #AAIC24 annual conference in Philadelphia. We hope to see you there! #AlzheimersDisease #AlzheimersAwareness

Including more underrepresented populations (URPs) in #AlzheimersDisease research is crucial for producing generalizable research findings and elucidating health disparities.¹,² Join the conversation at this year’s #AAIC24 #AlzheimersAwareness

Genes associated with the immune system have increasingly been associated with #AlzheimersDisease risk.¹,² Learn more about the neuroimmune axis at the #AAIC24​ #AlzheimersAwareness

After a successful five days, during which we discovered cutting-edge research in #AlzheimersDisease, the #AAIC24 comes to an end. Did you enjoy it as much as we did?

Did you enjoy the #AAIC24 in Philadelphia? One hot topic was the translation of #AlzheimersDisease biomarkers into clinical practice in an era of precision medicine. Watch Prof. Shi’s opinion on amyloid and tau here: #AlzheimersAwareness

Prof. Sylvain Lehmann shares how #AlzheimersDisease (AD) research and diagnosis have improved patient care. We asked him what the biggest innovation in AD in the last 3 years was. Watch his response here: #AlzheimersAwareness

Humans fear the future and uncertainties, says Prof. Sylvain Lehmann. Confirming the presence of#AlzheimersDisease by using biomarkers helps to provide an accurate diagnosis.¹⁻³ This allows individuals and care partners to prepare for the future.⁴ Watch his full answer here:

#WorldAlzheimersMonth What % of people diagnosed with #AlzheimersDisease are female?

We’re proud to support Alzheimer’s Disease International this #𝐖𝐨𝐫𝐥𝐝𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫𝐬𝐌𝐨𝐧𝐭𝐡 as we stand by their mission: prevention, care and inclusion. For several decades Lilly has been driving scientific progress in Alzheimer’s disease to improve patient outcomes.